| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/23/2004 | EP1430902A1 Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale |
| 06/23/2004 | EP1430887A1 Powder for inhalation containing Tiotropium |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 06/23/2004 | EP1430041A2 Novel sulfonic acid derivatives |
| 06/23/2004 | EP1430033A1 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 06/23/2004 | EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 06/23/2004 | EP1430024A1 Alkyl urea retinoid agonists i |
| 06/23/2004 | EP1430023A1 Substituied urea retinoid agonists ii |
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1429843A2 Combination of a pde inhibitor and a leukotriene receptor antagonist |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429775A1 Methods of treating pulmonary disease |
| 06/23/2004 | EP1429768A1 Novel medicaments for inhalation |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/23/2004 | EP1429751A1 Salicylic acid salts, methods for the production and use thereof as medicaments |
| 06/23/2004 | EP1429746A2 Dosage forms having an inner core and outer shell |
| 06/23/2004 | EP1429745A2 Composite dosage forms having an inlaid portion |
| 06/23/2004 | EP1429743A1 Dosage forms having an inner core and outer shell with different shapes |
| 06/23/2004 | EP1429742A2 Modified release dosage forms |
| 06/23/2004 | EP1429738A2 Modified release dosage forms |
| 06/23/2004 | EP1429737A1 Modified release dosage forms |
| 06/23/2004 | EP1429724A1 Dosage form containing a confectionery composition |
| 06/23/2004 | EP1429712A2 Method for treating bronchial constriction and bronchospasm |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1283731A4 Medicament container with same side airflow inlet and outlet and method of use |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1237851A4 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | EP0754069B1 Treatment of pulmonary vasoconstriction and asthma |
| 06/23/2004 | CN1507448A N-But-3-Enyl norbuprenophine and its use as analgesic |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507353A Compositions for use in treating IGE-associated disorders |
| 06/23/2004 | CN1506115A Calmette-Guerin bacillus prepn |
| 06/23/2004 | CN1506100A Medicine for treating acute and chronic bronchitis, asthma and pulmonary emphysema |
| 06/23/2004 | CN1506085A Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process |
| 06/23/2004 | CN1154650C Triazole-[4,5-d] pyrididines compound, its preparation, use and medical composition containing the same |
| 06/23/2004 | CN1154495C Use of mirtazapine for treating sleep apneas |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154485C Use of a specific antagonist of 5HTz receptors for preparing medicine useful for treating sleep-disordered breathing |
| 06/22/2004 | US6753427 2,6-disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/17/2004 | WO2004050631A1 Substituted dihydrophenanthridinesul fonamides |
| 06/17/2004 | WO2004050187A1 Use of hyaluronic acid for respiratory disorders or the upper airways |
| 06/17/2004 | WO2004050093A1 Tiotropium-containing medicament combinations used for inhaling |
| 06/17/2004 | WO2004050071A1 A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
| 06/17/2004 | WO2004050070A2 Composition comprising pseudoephedrine and domperidone for preventing snoring |
| 06/17/2004 | WO2004027421A3 Adp assay |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003097050A3 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| 06/17/2004 | WO2003070184A3 Sodium channel blockers |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116530 Tissue fibrosis inhibitors |
| 06/17/2004 | US20040116519 Anticholinergic agents such as 4-(diethylmethylaminium)-2-butynyl alpha phenyl cyclohexane glycolate iodide, used for prophylaxis of asthma, chronic obstructive pulmonary disease and rhinitis |
| 06/17/2004 | US20040116516 Pharmaceutical composition |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116501 Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116482 Potassium channel opener |
| 06/17/2004 | US20040116471 Indolylpiperidine derivatives as antihistaminic aand antiallergic agents |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116435 Benzimidazol derivatives modulate chemokine receptors |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116426 Small molecules useful in the treatment of inflammatory disease |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116395 Combinations for the treatment of inflammatory disorders |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040115690 Method of detecting inflammatory lung disorders |
| 06/17/2004 | US20040115309 Food supplement |
| 06/17/2004 | US20040115181 Composition for transmucosal adminstration containing conenzyme q as the active ingredient |
| 06/17/2004 | US20040115136 L-tartrate derivative; stable particle size distribution; reproducible dosing; can be stored under varying temperature and humidity conditions |
| 06/17/2004 | DE10256080A1 Tiotropiumhaltige Arzneimittelkombination für die Inhalation Tiotropiumhaltige drug combination for inhalation |
| 06/17/2004 | CA2508329A1 Substituted dihydrophenanthridinesul fonamides |